Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
240325_CP_ICFSR
By
admin
March 24, 2025
2025-03-17_PR_Biophytis_revolutionizes_Sarcopenia
By
admin
March 17, 2025
2025-03-17_CP_Biophytis_revolutionne_la_Sarcopenie
By
admin
March 17, 2025
060325_PR_Participation_BIO-Europe-Milan_EN
By
admin
March 6, 2025
060325_CP_Participation_BIO-Europe-Milan_FR
By
admin
March 6, 2025
25-02-2025_PR_Participation_ICFSR_EN
By
admin
February 25, 2025
25-02-2025_CP_Participation_ICFSR_FR
By
admin
February 25, 2025
2025-02-10_Biophytis_PR_Perspectives_2025_EN
By
admin
February 10, 2025
2025-02-10_Biophytis_CP_Perspectives_2025_FR
By
admin
February 10, 2025
2025-02_Lettre_aux_actionnaires-Biophytis_FR
By
admin
February 10, 2025
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
…
23
24
25
26
27
…
28
29
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
